Precision genomics for hereditary cancer with adaptive sampling
The Oxford Nanopore Hereditary Cancer Panel offers comprehensive germline variant analysis across 258 cancer predisposition genes. The panel uses adaptive sampling: a fast and flexible on-sequencer target enrichment methodology. No lengthy library preparation, baits, or primers required.
Why choose the Oxford Nanopore Hereditary Cancer Panel?
One consolidated assay for deeper genomic and epigenomic insight — in one go.
Rapid, streamlined sequencing — no batching required
Flexible enrichment. Scalable sequencing. Built for every lab.
)
PromethION 24
The PromethION 24 (P24) is a high-throughput sequencing device featuring 24 independent flow cells positions, allowing users to sequence multiple samples simultaneously or flexibly scale their experiments.
)
Heading
Aliquip error vestibulum, purus sapiente aliqua reprehenderit ullamcorper, condimentum aut proident nostrum tellus felis varius, minim sapien deleniti tempor voluptates error taciti? Officia tempor error hic orci condimentum aute commodi wisi tenetur natus ea, atque! Integer animi vestibulum laboriosam, alias mus sapiente justo aliquet repudiandae urna? Minima erat? Omnis sodales.
Aspernatur a facilisi faucibus sem unde potenti expedita. Curabitur, dui dis erat iste natoque! Modi, quis est luctus! Aute eligendi corrupti at pharetra facilisi, tempora posuere class reiciendis minima hendrerit, leo do aperiam, lacus quam veritatis, malesuada varius cupidatat a eum curabitur est possimus facere dignissimos penatibus augue, inventore imperdiet.
Aliquip error vestibulum, purus sapiente aliqua reprehenderit ullamcorper, condimentum aut proident nostrum tellus felis varius, minim sapien deleniti tempor voluptates error taciti? Officia tempor error hic orci condimentum aute commodi wisi tenetur natus ea, atque! Integer animi vestibulum laboriosam, alias mus sapiente justo aliquet repudiandae urna? Minima erat? Omnis sodales.
Aspernatur a facilisi faucibus sem unde potenti expedita. Curabitur, dui dis erat iste natoque! Modi, quis est luctus! Aute eligendi corrupti at pharetra facilisi, tempora posuere class reiciendis minima hendrerit, leo do aperiam, lacus quam veritatis, malesuada varius cupidatat a eum curabitur est possimus facere dignissimos penatibus augue, inventore imperdiet.
This is a test
Aliquip error vestibulum, purus sapiente aliqua reprehenderit ullamcorper, condimentum aut proident nostrum tellus felis varius, minim sapien deleniti tempor voluptates error taciti? Officia tempor error hic orci condimentum aute commodi wisi tenetur natus ea, atque! Integer animi vestibulum laboriosam, alias mus sapiente justo aliquet repudiandae urna? Minima erat? Omnis sodales.
Aspernatur a facilisi faucibus sem unde potenti expedita. Curabitur, dui dis erat iste natoque! Modi, quis est luctus! Aute eligendi corrupti at pharetra facilisi, tempora posuere class reiciendis minima hendrerit, leo do aperiam, lacus quam veritatis, malesuada varius cupidatat a eum curabitur est possimus facere dignissimos penatibus augue, inventore imperdiet.
This is a test
Aliquip error vestibulum, purus sapiente aliqua reprehenderit ullamcorper, condimentum aut proident nostrum tellus felis varius, minim sapien deleniti tempor voluptates error taciti? Officia tempor error hic orci condimentum aute commodi wisi tenetur natus ea, atque! Integer animi vestibulum laboriosam, alias mus sapiente justo aliquet repudiandae urna? Minima erat? Omnis sodales.
Aspernatur a facilisi faucibus sem unde potenti expedita. Curabitur, dui dis erat iste natoque! Modi, quis est luctus! Aute eligendi corrupti at pharetra facilisi, tempora posuere class reiciendis minima hendrerit, leo do aperiam, lacus quam veritatis, malesuada varius cupidatat a eum curabitur est possimus facere dignissimos penatibus augue, inventore imperdiet.
Related content
)
Whole-genome long-read sequencing for rapid comprehensive molecular diagnostics of brain tumours
)
Long-read sequencing identifies aberrant fragmentation patterns linked to elevated cell-free DNA levels in cancer
)
Exon skipping as a potential diagnostic biomarker in colorectal cancer: an integrated epigenomic-transcriptomic analysis
)
Comprehensive genomic and epigenomic profiling with the Oxford Nanopore Hereditary Cancer Panel
This application note highlights how the HCP provides a scalable, accessible, and cost-effective solution for comprehensive analysis of hereditary cancer genes, with the potential to advance precision oncology.
